Atlas Trials

Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance

Clinical trial NCT02930954 · UNKNOWN

Trial details

NCT number
NCT02930954
Sponsor
Caicun Zhou
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small-cell Lung Cancer
Start date
2016-11-01
Primary completion
2018-12-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.